Literature DB >> 28235690

Interplay between cancer cell cycle and metabolism: Challenges, targets and therapeutic opportunities.

Debmalya Roy1, Gao Ying Sheng2, Semukunzi Herve3, Evandro Carvalho4, Arpan Mahanty5, Shengtao Yuan6, Li Sun7.   

Abstract

A growing interest has emerged in the field of studying the cross-talk between cancer cell cycle and metabolism. In this review, we aimed to present how metabolism and cell cycle are correlated and how cancer cells get energy to drive cell cycle. Cell proliferation and cell death largely depend on the metabolic activity of the cell. Cell cycle proteins, e.g. cyclin D, cyclin dependent kinase (CDK), some pro-apoptotic and anti-apoptotic proteins, and P53 have been shown to be regulated by metabolic crosstalk. Dysregulation of this cross-talk between metabolism and cell cycle leads to degenerative disorder(s) and cancer. It is not fully understood the actual reason of aberration between metabolism and cell cycle, but it is a hallmark of cancer research. Herein, we discussed the role of some regulatory molecules relative of cell cycle and metabolism and highlight how they control the function of each other. We also pointed out, current therapeutic opportunities and some additional crucial therapeutic targets on these fields that could be a breakthrough in cancer research.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cell cycle; ErbB2; Glycolysis; Metabolism; PFKFB3; Pyruvate

Mesh:

Substances:

Year:  2017        PMID: 28235690     DOI: 10.1016/j.biopha.2017.01.019

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  16 in total

1.  Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis.

Authors:  Ruru Zhu; Jisen Xue; Huijun Chen; Qian Zhang
Journal:  Oncol Lett       Date:  2020-08-21       Impact factor: 2.967

2.  Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery.

Authors:  Sylvie Skalickova; Martin Loffelmann; Michael Gargulak; Marta Kepinska; Michaela Docekalova; Dagmar Uhlirova; Martina Stankova; Carlos Fernandez; Halina Milnerowicz; Branislav Ruttkay-Nedecky; Rene Kizek
Journal:  Nanomaterials (Basel)       Date:  2017-12-08       Impact factor: 5.076

3.  Random Parametric Perturbations of Gene Regulatory Circuit Uncover State Transitions in Cell Cycle.

Authors:  Ataur Katebi; Vivek Kohar; Mingyang Lu
Journal:  iScience       Date:  2020-05-11

4.  Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging.

Authors:  Masoud Sadeghzadeh; Barbara Wenzel; Daniel Gündel; Winnie Deuther-Conrad; Magali Toussaint; Rareş-Petru Moldovan; Steffen Fischer; Friedrich-Alexander Ludwig; Rodrigo Teodoro; Shirisha Jonnalagadda; Sravan K Jonnalagadda; Gerrit Schüürmann; Venkatram R Mereddy; Lester R Drewes; Peter Brust
Journal:  Molecules       Date:  2020-05-14       Impact factor: 4.411

5.  AURKB: a promising biomarker in clear cell renal cell carcinoma.

Authors:  Bangbei Wan; Yuan Huang; Bo Liu; Likui Lu; Cai Lv
Journal:  PeerJ       Date:  2019-09-16       Impact factor: 2.984

6.  Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism.

Authors:  Jérôme Ruhnau; Jonas Parczyk; Kerstin Danker; Britta Eickholt; Andreas Klein
Journal:  BMC Cancer       Date:  2020-07-02       Impact factor: 4.430

7.  8-Chloro-Adenosine Inhibits Proliferation of MDA-MB-231 and SK-BR-3 Breast Cancer Cells by Regulating ADAR1/p53 Signaling Pathway.

Authors:  Hong-Yue Ding; Wan-Yong Yang; Li-Hong Zhang; Li Li; Feng Xie; Hua-Yi Li; Xiao-Yu Chen; Zeng Tu; Yi Li; Yong Chen; Sheng-Yong Yang
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

8.  Integrated Analysis of Circular RNA-Associated ceRNA Network Reveals Potential circRNA Biomarkers in Human Breast Cancer.

Authors:  Han Sheng; Huan Pan; Ming Yao; Longsheng Xu; Jianju Lu; Beibei Liu; Jianfen Shen; Hui Shen
Journal:  Comput Math Methods Med       Date:  2021-12-20       Impact factor: 2.238

9.  Bromodomains and Extra-Terminal (BET) Inhibitor JQ1 Suppresses Proliferation of Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolysis.

Authors:  Meng-Yi Zhang; Sheng-Li Liu; Wen-Li Huang; Da-Bin Tang; Wei-Wei Zheng; Neng Zhou; Hang Zhou; Tuersunayi Abudureheman; Zhong-Hua Tang; Bin-Bing S Zhou; Cai-Wen Duan
Journal:  Med Sci Monit       Date:  2020-04-08

10.  CENPE promotes glioblastomas proliferation by directly binding to WEE1.

Authors:  Chuanling Ma; Jianchao Wang; Jie Zhou; Kaisen Liao; Min Yang; Fangqiong Li; Meng Zhang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.